<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>BIOBUSINESS Collaborations &amp; Agreements  news from GEN</title><description>Discusses licensing deals and collaborations involving biotech and pharma companies.</description>
<lastBuildDate>Thursday, March 13, 2008</lastBuildDate><link>http://www.genengnews.com/news/newslist.aspx?taxid=3</link>
<item>
<title>Salix Acquires Budesonide Products from Dr. Falk Pharma</title>
<description></description>
<pubDate>Thursday, March 13, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=32010158</link>
</item>
<item>
<title>Roche NimbleGen and Affymetrix Expand Licensing Agreement</title>
<description></description>
<pubDate>Thursday, March 13, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=32005196</link>
</item>
<item>
<title>Power3 Medical Initiates Three Hundred Patient Clinical Validation Study of Its Nuropro(R) Diagnostic Test for Alzheimer's and Parkinson's Disease</title>
<description></description>
<pubDate>Thursday, March 13, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=32004335</link>
</item>
<item>
<title>Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals</title>
<description></description>
<pubDate>Thursday, March 13, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=32001875</link>
</item>
<item>
<title>Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery</title>
<description></description>
<pubDate>Thursday, March 13, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=32011190</link>
</item>
<item>
<title>Lev Announces FDA's Blood Products Advisory Committee to Review Cinryze (TM) (C1 inhibitor)</title>
<description></description>
<pubDate>Thursday, March 13, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=32000260</link>
</item>
<item>
<title>AVI BioPharma Announces Acquisition of Ercole Biotech</title>
<description></description>
<pubDate>Thursday, March 13, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31992941</link>
</item>
<item>
<title>Initial Trading of RXi Pharmaceuticals Begins Today on the NASDAQ Capital Market Under Symbol RXII</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31948945</link>
</item>
<item>
<title>Collexis Unveils Enhanced Services for Premier Online Scientific Social Network Community, BioMedExperts</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31947326</link>
</item>
<item>
<title>Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31946500</link>
</item>
<item>
<title>Power3 Medical Products Inc. Publishes Discovery of Protein Biomarkers for Esophageal Malignancies in the International Journal of Cancer</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31944878</link>
</item>
<item>
<title>Cytori Reports 4th Quarter and Year End Results; Provides Update on Commercialization Progress</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31943304</link>
</item>
<item>
<title>TPG Biotech to Fund Development of JCR Pharmaceuticals Drug Candidates</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31943309</link>
</item>
<item>
<title>Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31951602</link>
</item>
<item>
<title>China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31949140</link>
</item>
<item>
<title>ImmuCell Announces Cross-License With Anadis</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31944402</link>
</item>
<item>
<title>QuantRx(R) Biomedical Announces Expansion of Its International
Intellectual Property</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31944406</link>
</item>
<item>
<title>Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31945914</link>
</item>
<item>
<title>Raven biotechnologies Advances RAV18 Through Agreement With CMC ICOS Biologics</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31943502</link>
</item>
<item>
<title>ProMetic announces strategic alliance agreement with Wuhan Institute of Biological Products for the implementation of plasma fractionation technology in China</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31942720</link>
</item>
<item>
<title>FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31941937</link>
</item>
<item>
<title>Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs</title>
<description></description>
<pubDate>Wednesday, March 12, 2008</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=31938821</link>
</item>
</channel>
</rss>
